TBC1D12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.270000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.853990E-01
Normal-vs-Stage2
4.621700E-02
Normal-vs-Stage3
4.039800E-02
Normal-vs-Stage4
6.303200E-01
Stage1-vs-Stage2
7.400800E-01
Stage1-vs-Stage3
1.233360E-01
Stage1-vs-Stage4
4.989600E-01
Stage2-vs-Stage3
1.661970E-01
Stage2-vs-Stage4
2.101000E-01
Stage3-vs-Stage4
1.245840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.098400E-02
Normal-vs-AfricanAmerican
3.044000E-01
Normal-vs-Asian
4.221800E-02
Caucasian-vs-AfricanAmerican
4.589600E-01
Caucasian-vs-Asian
3.380600E-01
AfricanAmerican-vs-Asian
2.496000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.227800E-02
Normal-vs-Female
4.262100E-02
Male-vs-Female
7.951400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.157200E-01
Normal-vs-Age(41-60Yrs)
1.368160E-01
Normal-vs-Age(61-80Yrs)
2.772400E-02
Normal-vs-Age(81-100Yrs)
3.872400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.985800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.422200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.042200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.962200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.362230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.407800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.669670E-02
Normal-vs-Daily Drinker
3.378300E-02
Normal-vs-Weekly Drinker
3.751700E-02
Normal-vs-Occasional Drinker
6.380400E-02
Normal-vs-Social Drinker
2.198200E-01
Non Drinker-vs-Daily Drinker
6.075000E-01
Non Drinker-vs-Weekly Drinker
8.497600E-01
Non Drinker-vs-Occasional Drinker
3.996800E-01
Non Drinker-vs-Social Drinker
4.314200E-01
Daily Drinker-vs-Weekly Drinker
8.085600E-01
Daily Drinker-vs-Occasional Drinker
2.587800E-01
Daily Drinker-vs-Social Drinker
2.693400E-01
Weekly Drinker-vs-Occasional Drinker
3.978000E-01
Weekly Drinker-vs-Social Drinker
4.100600E-01
Occasional Drinker-vs-Social Drinker
8.333000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.921170E-01
Normal-vs-Grade 2
4.602200E-02
Normal-vs-Grade 3
5.402000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.556210E-01
Grade 1-vs-Grade 3
2.212800E-01
Grade 1-vs-Grade 4
1.921170E-01
Grade 2-vs-Grade 3
9.779000E-01
Grade 2-vs-Grade 4
4.602200E-02
Grade 3-vs-Grade 4
5.402000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.843700E-02
Normal-vs-NonDiabetic
2.110400E-02
Diabetic-vs-NonDiabetic
9.777400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.923700E-02
Normal-vs-NoPancreatitis
2.807800E-02
Pancreatitis-vs-NoPancreatitis
5.223800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.030100E-02
Normal-vs-N1
4.063600E-02
N0-vs-N1
7.115400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.652100E-02
Normal-vs-TP53-NonMutant
1.261430E-01
TP53-Mutant-vs-TP53-NonMutant
1.901030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
